USP 621 Thin Layer Chromatography glp records performed during the development of

performed during the development of a new drug product

The selection

or any other abnormal source of microbial contamination

Equipment must be adequately maintained as part of a preventive maintenance program to protect components and dietary supplements from being contaminated by any source

SOP and report form for testing for the absence or presence of Salmonella in products or materials according to USP <62> and EP 2

USP 621 Thin Layer Chromatography glp records performed during the development ofSOP for the use of TLC by Quality Control to separate mixtures of compounds or analytes using a solvent mobile phase and plate to confirm presence or purity of a substance